Jianqing Xu Selected Research

Kidney Neoplasms (Kidney Cancer)

9/2022

Comprehensive RNA-seq reveals molecular changes in kidney malignancy among people living with HIV.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianqing Xu Research Topics

Disease

44	Infections 01/2022 - 03/2002
18	Human Influenza (Influenza) 01/2022 - 11/2006
17	Neoplasms (Cancer) 09/2022 - 09/2010
15	Vaccinia 08/2021 - 05/2003
14	COVID-19 02/2022 - 01/2020
8	Inflammation (Inflammations) 11/2021 - 01/2012
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 01/2005
5	Virus Diseases (Viral Diseases) 01/2021 - 01/2016
4	Persistent Infection 11/2017 - 01/2005
3	HIV Infections (HIV Infection) 09/2022 - 01/2018
3	Pneumonia (Pneumonitis) 11/2021 - 01/2014
3	Communicable Diseases (Infectious Diseases) 01/2021 - 09/2008
3	Tuberculosis (Tuberculoses) 12/2020 - 01/2015
3	Zika Virus Infection 01/2020 - 08/2017
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2014
2	Hypoxia (Hypoxemia) 10/2021 - 10/2020
2	Cough 01/2021 - 08/2020
2	Disease Progression 01/2021 - 02/2016
2	Astrocytoma (Pilocytic Astrocytoma) 01/2020 - 04/2014
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 02/2016
2	Influenza in Birds (Avian Flu) 09/2016 - 01/2012
2	Glioma (Gliomas) 04/2014 - 01/2014
1	Kidney Neoplasms (Kidney Cancer) 09/2022
1	Chronic Renal Insufficiency 07/2022
1	Insulin Resistance 07/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Bites and Stings (Sting) 01/2022
1	Spasm (Spasms) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Reinfection 01/2022

Drug/Important Bio-Agent (IBA)

28	VaccinesIBA 01/2022 - 01/2005
17	Proteins (Proteins, Gene)FDA Link 09/2022 - 05/2008
14	AntigensIBA 01/2022 - 05/2003
11	AntibodiesIBA 01/2022 - 01/2011
9	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2007
9	CytokinesIBA 11/2021 - 01/2014
7	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 11/2006
7	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2016
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2016
5	Immunoglobulin G (IgG)IBA 09/2022 - 12/2007
5	Neutralizing AntibodiesIBA 01/2022 - 11/2012
5	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 12/2013
5	Peptides (Polypeptides)IBA 01/2018 - 05/2003
5	DNA VaccinesIBA 12/2017 - 06/2007
4	Messenger RNA (mRNA)IBA 09/2022 - 01/2017
4	Interferon Type IIBA 01/2022 - 08/2017
4	Monoclonal AntibodiesIBA 10/2020 - 01/2017
4	EpitopesIBA 01/2020 - 05/2013
3	RNA (Ribonucleic Acid)IBA 09/2022 - 08/2017
3	EnzymesIBA 02/2022 - 01/2017
3	InterferonsIBA 01/2022 - 01/2014
3	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 10/2015
3	Chimeric Antigen ReceptorsIBA 10/2021 - 10/2020
3	Viral RNAIBA 01/2021 - 02/2014
3	Recombinant DNA (Recombinant DNA Research)IBA 01/2019 - 05/2014
2	LipopolysaccharidesIBA 09/2022 - 01/2017
2	ImmunosorbentsIBA 02/2022 - 01/2017
2	HymecromoneIBA 02/2022 - 01/2022
2	Hyaluronic Acid (Hyaluronan)IBA 02/2022 - 01/2022
2	Therapeutic UsesIBA 01/2022 - 06/2017
2	Glycoproteins (Glycoprotein)IBA 12/2021 - 01/2016
2	GP 140IBA 08/2021 - 06/2009
2	Biological ProductsIBA 05/2021 - 01/2015
2	InterleukinsIBA 01/2021 - 09/2015
2	HLA-DR Antigens (HLA-DR)IBA 01/2021 - 05/2003
2	LigandsIBA 11/2020 - 06/2017
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020 - 01/2018
2	Long Noncoding RNAIBA 01/2020 - 04/2017
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 12/2007
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2017 - 06/2017
2	Anti-Infective Agents (Microbicides)IBA 02/2016 - 01/2012
2	Immunoglobulin A (IgA)IBA 01/2015 - 12/2007
2	DermaVirIBA 01/2005 - 01/2005
1	Kisspeptin-1 ReceptorsIBA 09/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022
1	Vitamin D FDA LinkGeneric 07/2022
1	fibrin fragment D (D-dimer)IBA 02/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Prescription DrugsIBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2022
1	Non-Receptor Type 6 Protein Tyrosine PhosphataseIBA 01/2022
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 12/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2021
1	Bovine Serum AlbuminIBA 06/2021
1	Adenovirus VaccinesIBA 06/2021

Therapy/Procedure

8	Immunotherapy 01/2022 - 01/2016
8	Therapeutics 01/2022 - 03/2002
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2014
1	Lasers (Laser) 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2021